Events

Alerte De Sécurité sur FreeStyle Lite blood glucose test strips

Selon Department of Health, ce/cet/cette alerte de sécurité concerne un dispositif en/au/aux/à Hong Kong qui a été fabriqué par Abbott Diabetes Care.

Qu'est-ce que c'est?

Les alertes fournissent des informations importantes et des recommandations concernant les dispositifs médicaux. Le fait qu'une alerte soit émise ne signifie pas nécessairement qu'un dispositif soit dangereux. Les alertes de sécurité, qui sont envoyées tant aux travailleurs du secteur médical qu'aux utilisateurs de ces dispositifs, peuvent inclure des rappels. Elles peuvent être rédigées par des fabricants mais aussi par des autorités en charge de la santé.

En savoir plus sur les données ici
  • Type d'événement
    Safety alert
  • Date
    2013-11-26
  • Pays de l'événement
    Hong Kong
  • Source de l'événement
    DH
  • URL de la source de l'événement
    https://www.mdco.gov.hk/english/safety/recalls/recalls_20131126a.html
  • Notes / Alertes
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
  • Notes supplémentaires dans les données
    Press release
  • Cause
    Further recall of selected lots of freestyle lite blood glucose test strips the department of health (dh) today (november 26) drew public attention to abbott diabetes care's further recall of other selected lots of its freestyle lite blood glucose test strips due to the potential for giving erroneously low blood glucose results when used in conjunction with certain brands of blood glucose meters also manufactured by the company. further to the press release issued by the dh yesterday (november 25) on the recall of certain lots of freestyle and freestyle lite blood glucose test strips by abbott diabetes care, the department, through its routine surveillance on medical devices, noticed abbott diabetes care's recall notice posted by the united kingdom's medicines and healthcare products regulatory agency involving three other lots of freestyle lite blood glucose test strips (lot numbers: 1284962, 1366626 and 1372611). according to the notice, the three affected lots may produce erroneously low blood glucose results and out of range control solution results when used in conjunction with freestyle blood glucose meters, freestyle mini blood glucose meters, freestyle navigator and the freestyle meter built into the omnipodsystem. a spokesman for the dh explained that falsely low blood glucose readings may mislead a diabetic patient into inappropriate management of his or her condition, resulting in hyperglycaemia. "preliminary enquiries with the local supplier, abbott laboratories limited, revealed no evidence of the affected products having been distributed in hong kong. the dh will continue to monitor the situation," the spokesman said. so far, the dh has not received any local reports of adverse events arising from use of the affected products. people who have the test strips belonging to the affected lots and are using the specific brands of glucose meters concerned should contact abbott laboratories limited for advice and follow-up," the spokesman stressed. the company has set up a customer service hotline, 5808 4196, to answer related enquiries. ends.

Device

FreeStyle Lite blood glucose test strips
  • Modèle / numéro de série
  • Description du dispositif
    Press release: Further recall of selected lots of FreeStyle Lite blood glucose test strips
  • Manufacturer
    Abbott Diabetes Care

Manufacturer

Abbott Diabetes Care
  • Société-mère du fabricant (2017)
    Abbott Laboratories
  • Commentaire du fabricant
    “We are in constant communication with regulatory agencies and competent authorities worldwide which allows us to implement global recalls or in-country communication quickly and effectively,” Abbott, which now owns St. Jude Medical told ICIJ in a statement. In addition to sending global notices to physicians worldwide, we also make sure that product advisories are available online and classification of product recalls and product advisories are determined by global regulatory bodies which can impact the timing in any given country. MD companies follow varying regulations in different countries. In come countries software is not regulated so a recall in one country related to software would not be classified as a recall or field action in another. In addition, review cycles within the regulatory process can be different in each country which can impact communication and recall timing.
  • Source
    DH